Histone deacetylase inhibitory and cytotoxic activities of the constituents from the roots of three species of Ferula

Document Type: Original Article

Authors

1 Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

2 Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Objective(s): Histone deacetylase inhibitory and cytotoxic activities of 18 naturally occuring terpenoids (ferutinin, stylosin, tschimgine and guaiol), coumarins (umbelliprenin, farnesiferone B, conferone, feselol, ligupersin A, conferdione, conferoside) and sulfur-containing derivatives (latisulfies A-E, persicasulphides A and C) from the roots of three species of Ferula (Ferula latisecta, Ferula ovina and Ferula flabelliloba) were evaluated.
Materials and Methods: The cytotoxic activity of compounds was evaluated against human cancer cell lines (HeLa, HCT116, A2780 and A549) by AlamarBlue® assay using vorinostat as the positive control. On the other hand, we aimed to evaluate their inhibitory activities against pan-HDAC.
Results: The methanolic extract of the roots of F. flabelliloba was subjected to silica gel column chromatography. Further purification by preparative thin-layer chromatography (PTLC) and semipreparative RP-HPLC yielded twelve known compounds (1-12). This is the first report on the isolation of guaiol (1), persicasulphide C (3) and conferoside (10) from the roots of F. flabelliloba. Six compounds including persicasulfide A, conferone, feselol, latisufide C, conferoside and ferutinin showed cytotoxic activity with IC50 values in the range of 11.61-49.40 μM against cancer cells and pan-HDAC inhibitory activity with IC50 values in the range of 1.06-35.27 μM.
Conclusion: Results indicated that persicasulfide A (2), conferone (6) and feselol (7) showed moderate cytotoxicity with IC50 values in the range of 11.76-39.24 μM against cancer cells and potent pan-HDAC inhibitory activity with IC50 values in the range of 1.06-10.73 μM. Conferone was more active than others with a higher potency for HDAC inhibition (1.06- 1.17 μM).

Keywords

Main Subjects


1. Roche J, Bertrand P. Inside HDACs with more selective HDAC inhibitors. Eur J Med Chem 2016; 121:451-483.
2. Ellis L, Atadja PW, Johnstone RW. Epigenetics in cancer: targeting chromatin modifications. Mol Cancer Ther 2009; 8:1409-1420.
3. Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 2006; 6:38-51.
4. Pimenov M, Leonov M. The Asian Umbelliferae biodiversity database (ASIUM) with particular reference to South-West Asian taxa. Turk J Bot 2004; 28:139-145.
5. Kajimoto T, Yahiro K, Nohara T. Sesquiterpenoid and disulphide derivatives from Ferula assa-foetida. Phytochemistry 1989; 28:1761-1763.
6. Iranshahi M, Noroozi S, Behravan J, Karimi G, Schneider B. Persicasulphide C, a new sulphur-containing derivative from Ferula persica. Nat Prod Res 2009; 23:1584-1588.
7. Iranshahi M, Hassanzadeh-Khayat M, Fazly Bazzaz BS, Sabeti Z, Enayati F. High content of polysulphides in the volatile oil of Ferula latisecta Rech. F. et Aell. fruits and antimicrobial activity of the oil. J Essent Oil Res 2008; 20:183-185.
8. Sattar Z, Iranshahi M. Phytochemistry and pharmacology of Ferula persica Boiss.: A review. Iran J Basic Med Sci 2017; 20:1-8.
9. Nazari Z, Iranshahi M. Biologically active sesquiterpene coumarins from Ferula species. Phytother Res 2011; 25:315-323.
10. Iranshahi M, Fata A, Emami B, Shahri BJ, Fazly Bazzaz BS. In vitro antifungal activity of polysulfides-rich essential oil of Ferula latisecta fruits against human pathogenic dermatophytes. Nat Prod Commun 2008; 3:1543-1546.
11. Soltani S, Amin G-R, Salehi-Sourmaghi MH, Schneider B, Lorenz S, Iranshahi M. Sulfur-containing compounds from the roots of Ferula latisecta and their cytotoxic activities. Fitoterapia 2018; 124:108-112.
12. Balasubramanian S, Verner E, Buggy JJ. Isoform-specific histone deacetylase inhibitors: the next step? Cancer Lett 2009; 280:211-221.
13.Bertrand P. Inside HDAC with HDAC inhibitors. Eur J Med Chem 2010; 45:2095-2116.
14. Ciossek T, Julius H, Wieland H, Maier T, Beckers T. A homogeneous cellular histone deacetylase assay suitable for compound profiling and robotic screening. Anal Biochem 2008; 372:72-81.
15. Iranshahi M, Famili A, Bassarello C, Piacente S, Pizza C. Purification and structure elucidation of compounds from the roots of Ferula ovina Boiss. J Med Plants Res 2010; 4:72-80.
16. O’brien J, Wilson I, Orton T, Pognan F. Investigation of the AlamarBlue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 2000; 267:5421-5426.
17. Marek L, Hamacher A, Hansen FK, Kuna K, Gohlke H, Kassack MU, et al. Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells. J Med Chem 2013; 56:427-436.
18. Zwick V, Allard PM, Ory L, Simões‐Pires CA, Marcourt L, Gindro K, et al. UHPLC‐MS‐based HDAC assay applied to bio‐guided microfractionation of fungal extracts. Phytochem Anal 2017; 28:93-100.
19. Iranshahi M, Amin G, Shafiee A. A new coumarin from Ferula persica. Pharm Biol 2004; 42:440-442.
20. Iranshahi M, Barthomeuf C, Bayet-Robert M, Chollet P, Davoodi D, Piacente S, et al. Drimane-type sesquiterpene coumarins from Ferula gummosa fruits enhance doxorubicin uptake in doxorubicin-resistant human breast cancer cell line. J tradit complement med 2014; 4:118-125.
21. Münchberg U, Anwar A, Mecklenburg S, Jacob C. Polysulfides as biologically active ingredients of garlic. Org Biomol Chem 2007; 5:1505-1518.
22. Shokoohinia Y, Chianese G, Appendino G, Di Marzo V, De Petrocellis L, Ghannadi A, et al. Some like it pungent and vile. TRPA1 as a molecular target for the malodorous vinyl disulfides from asafoetida. Fitoterapia 2013; 90:247-251.
23. Ho R, Nievergelt A, Pires CS, Cuendet M. Histone deacetylases as cancer chemoprevention targets for natural products. Stud Nat Prod Chem 2012; 38:247-267.
24. Nian H, Delage B, Ho E, Dashwood RH. Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds. Environmental and molecular mutagenesis 2009; 50:213-221.
25. Nian H, Delage B, Pinto JT, Dashwood RH. Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter. Carcinogenesis 2008; 29:1816-1824.
26. Barthomeuf C, Demeule M, Grassi J, Saidkhodjaev A, Beliveau R. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport. Planta Med 2006; 72:634-639.
27. Valiahdi SM, Iranshahi M, Sahebkar A. Cytotoxic activities of phytochemicals from Ferula species. DARU J Pharm Sci 2013; 21:39.
28. Cheraghi O, Dehghan G, Mahdavi M, Rahbarghazi R, Rezabakhsh A, Charoudeh HN, et al. Potent anti-angiogenic and cytotoxic effect of conferone on human colorectal adenocarcinoma HT-29 cells. Phytomedicine 2016; 23:398-405.
29. Okada T, Tanaka K, Nakatani F, Sakimura R, Matsunobu T, Li X, et al. Involvement of P‐glycoprotein and MRP1 in resistance to cyclic tetrapeptide subfamily of histone deacetylase inhibitors in the drug‐resistant osteosarcoma and Ewing’s sarcoma cells. In J Cancer 2006; 118:90-97.
30. Kim YK, Kim NH, Hwang JW, Song Y-J, Park Y-S, Seo D-W, et al. Histone deacetylase inhibitor apicidin-mediated drug resistance: involvement of P-glycoprotein. Biochem Biophys Res Commun 2008; 368:959-964.
31. Xiao JJ, Foraker AB, Swaan PW, Liu S, Huang Y, Dai Z, et al. Efflux of Depsipeptide FK228 (FR901228, NSC-630176) Is Mediated by P-Glycoprotein and Multidrug Resistance-Associated Protein 1. J Pharmacol Exp Ther 2005; 313:268-276.
32. Shahwar D, Raza MA, Shafiq-Ur-Rehman, Abbasi MA, Atta-Ur-Rahman. An investigation of phenolic compounds from plant sources as trypsin inhibitors. Nat Prod Res 2012; 26:1087-1093.
33. Shee C, Sharma AK. Purification and characterization of a trypsin inhibitor from seeds of Murraya koenigii. J Enzyme Inhib Med Chem 2007; 22:115-120.